Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation
- PMID: 17621815
- DOI: 10.2500/ajr.2007.21.3017
Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation
Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by abnormal angiogenesis with resultant telangiectasia formation in mucocutaneous tissues, visceral organs, and the central nervous system. The most common manifestation of HHT is epistaxis resulting from trauma to thin-walled telangiectasias. Many patients with HHT experience worsened epistaxis due to the presence of a septal perforation. Septal perforation in HHT patients results from aggressive noncartilage sparing treatments such as monopolar cauterization. Although the mainstay of treatment for patients with severe transfusion-dependent HHT remains to be septal dermoplasty (SD), patients with a septal perforation are less likely to have a successful outcome. In this small subset of patients, septectomy (ST) combined with SD is proposed to eliminate this variable to improve skin graft uptake and therefore outcome. This study reviews the indications, procedure, and outcome of nine patients with severe transfusion-dependent HHT and septal perforation who underwent the combined procedure of SD/ST.
Methods: Nine HHT patients with severe transfusion-dependent epistaxis and septal perforation underwent SD/ST at our institution over a 5-year period. Quality of life, including number of daily events of epistaxis, and transfusion requirements were determined before and after surgery. Technical aspects of the procedure as well as complications were reviewed.
Results: The combined procedure of SD/ST resulted in a long-lasting subjective improvement in quality of life for all patients. Similarly, transfusion requirements were reduced from 22.61 to 9.57 (p < 0.05). There were no complications or increased morbidity from the procedure.
Conclusion: Combined SD/ST is a safe and effective treatment for HHT patients with transfusion-dependent epistaxis and septal perforation.
Similar articles
-
Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.Laryngoscope. 2005 Feb;115(2):301-5. doi: 10.1097/01.mlg.0000154754.39797.43. Laryngoscope. 2005. PMID: 15689755
-
Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.Otolaryngol Head Neck Surg. 2008 Jun;138(6):721-4. doi: 10.1016/j.otohns.2008.01.005. Otolaryngol Head Neck Surg. 2008. PMID: 18503842
-
A new method of nasal dermoplasty (MW grafting method) in patients with large septal perforation.Laryngoscope. 2011 Aug;121(8):1715-7. doi: 10.1002/lary.21875. Laryngoscope. 2011. PMID: 21792959
-
Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia.J Craniofac Surg. 2014;25(2):e120-2. doi: 10.1097/SCS.0000000000000453. J Craniofac Surg. 2014. PMID: 24469376 Review.
-
[Nasal cavity dermoplasty as a treatment of recurrent bleeding in Rendu-Osler-Weber's disease].Otolaryngol Pol. 2007;61(1):74-9. doi: 10.1016/s0030-6657(07)70387-6. Otolaryngol Pol. 2007. PMID: 17605423 Review. Polish.
Cited by
-
Hereditary Hemorrhagic Telangiectasia With Multiple Ear, Nose, and Throat (ENT) Manifestations: A Case Report.Cureus. 2023 Jul 30;15(7):e42706. doi: 10.7759/cureus.42706. eCollection 2023 Jul. Cureus. 2023. PMID: 37654935 Free PMC article.
-
Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.Acta Otorhinolaryngol Ital. 2021 Feb;41(1):59-68. doi: 10.14639/0392-100X-N0915. Acta Otorhinolaryngol Ital. 2021. PMID: 33746224 Free PMC article.
-
Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management.J Otolaryngol Head Neck Surg. 2016 Jan 12;45:3. doi: 10.1186/s40463-016-0116-8. J Otolaryngol Head Neck Surg. 2016. PMID: 26754744 Free PMC article. Review.
-
Silicone septal splint for recurrent epistaxis in HHT patients: experience of a national referral centre.Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S28-S33. doi: 10.14639/0392-100X-suppl.1-43-2023-03. Acta Otorhinolaryngol Ital. 2023. PMID: 37698097 Free PMC article.
-
Long-term efficacy assessment of current treatment options for epistaxis in HHT.Eur Arch Otorhinolaryngol. 2021 Nov;278(11):4321-4328. doi: 10.1007/s00405-021-06701-z. Epub 2021 Mar 4. Eur Arch Otorhinolaryngol. 2021. PMID: 33661356 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical